175 related articles for article (PubMed ID: 22791811)
1. Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells.
Dahlman-Wright K; Qiao Y; Jonsson P; Gustafsson JÅ; Williams C; Zhao C
Carcinogenesis; 2012 Sep; 33(9):1684-91. PubMed ID: 22791811
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.
Babu RL; Naveen Kumar M; Patil RH; Devaraju KS; Ramesh GT; Sharma SC
Mol Cell Biochem; 2013 Aug; 380(1-2):143-51. PubMed ID: 23625206
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1.
Zhao C; Gao H; Liu Y; Papoutsi Z; Jaffrey S; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2010 Jun; 70(12):5174-83. PubMed ID: 20501845
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation.
Stender JD; Frasor J; Komm B; Chang KC; Kraus WL; Katzenellenbogen BS
Mol Endocrinol; 2007 Sep; 21(9):2112-23. PubMed ID: 17550982
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
7. c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer.
He H; Sinha I; Fan R; Haldosen LA; Yan F; Zhao C; Dahlman-Wright K
Oncogene; 2018 May; 37(19):2586-2600. PubMed ID: 29467493
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.
Zhong J; Cao RX; Zu XY; Hong T; Yang J; Liu L; Xiao XH; Ding WJ; Zhao Q; Liu JH; Wen GB
FEBS J; 2012 Jan; 279(2):316-35. PubMed ID: 22093364
[TBL] [Abstract][Full Text] [Related]
9. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
10. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
11. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
Petz LN; Ziegler YS; Schultz JR; Nardulli AM
Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
[TBL] [Abstract][Full Text] [Related]
12. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
Band AM; Laiho M
Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.
Cherlet T; Murphy LC
Mol Cell Biochem; 2007 Dec; 306(1-2):33-42. PubMed ID: 17660955
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptor α variants and c-Fos in rat mammary gland and tumors.
Gutiérrez A; Sambuco L; Álvarez L; Núñez M; Bergoc R; Zotta E; Martín G; Randi A
J Steroid Biochem Mol Biol; 2020 May; 199():105594. PubMed ID: 31968225
[TBL] [Abstract][Full Text] [Related]
15. Myocardin inhibits estrogen receptor alpha-mediated proliferation of human breast cancer MCF-7 cells via regulating MicroRNA expression.
Xiang Y; Lu DL; Li JP; Yu CX; Zheng DL; Huang X; Wang ZY; Hu P; Liao XH; Zhang TC
IUBMB Life; 2016 Jun; 68(6):477-87. PubMed ID: 27156566
[TBL] [Abstract][Full Text] [Related]
16. Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1.
Cheung E; Acevedo ML; Cole PA; Kraus WL
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):559-64. PubMed ID: 15642950
[TBL] [Abstract][Full Text] [Related]
17. The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.
Chand AL; Wijayakumara DD; Knower KC; Herridge KA; Howard TL; Lazarus KA; Clyne CD
PLoS One; 2012; 7(2):e31593. PubMed ID: 22359603
[TBL] [Abstract][Full Text] [Related]
18. Estrogen increases the transcription of human α2-Heremans-Schmid-glycoprotein by an interplay of estrogen receptor α and activator protein-1.
Qiu C; Liu X; Wang J; Zhao Y; Fu Q
Osteoporos Int; 2014 Apr; 25(4):1357-67. PubMed ID: 24504099
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha and the activating protein-1 complex cooperate during insulin-like growth factor-I-induced transcriptional activation of the pS2/TFF1 gene.
Baron S; Escande A; Albérola G; Bystricky K; Balaguer P; Richard-Foy H
J Biol Chem; 2007 Apr; 282(16):11732-41. PubMed ID: 17317669
[TBL] [Abstract][Full Text] [Related]
20. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
